These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Conservative treatment of ulcerative colitis and Crohn's disease in childhood]. Bläker F Monatsschr Kinderheilkd; 1981 Feb; 129(2):117-8. PubMed ID: 6112669 [No Abstract] [Full Text] [Related]
6. The leukocyte count predicts the efficacy of treatment with azathioprine in inflammatory bowel disease. Glas J; Török HP; Daczo J; Tonenchi L; Folwaczny M; Folwaczny C Eur J Med Res; 2005 Dec; 10(12):535-8. PubMed ID: 16356870 [TBL] [Abstract][Full Text] [Related]
7. [Long-term therapy in ulcerative colitis and Crohn's disease]. Malchow H Fortschr Med; 1979 Aug; 97(29):1253-60. PubMed ID: 457018 [TBL] [Abstract][Full Text] [Related]
9. [Immunodepressants in the treatment of Crohn's disease and non-specific ulcerative colitis]. Radbil' OS Klin Med (Mosk); 1976 Mar; 54(3):8-14. PubMed ID: 787661 [No Abstract] [Full Text] [Related]
11. [Failure of disodium cromoglycate in the treatment of 17 patients with chronic inflammatory diseases of the intestine. An occasion to review the pathogenetic problems of ulcerative rectocolitis and Crohn's disease]. Franchi F; Meneghelli M; Seminara P; Spadini M; Bonomo R Minerva Dietol Gastroenterol; 1982; 28(4):285-91. PubMed ID: 6820127 [No Abstract] [Full Text] [Related]
12. [For treatment decision the age to be taken into account. In Crohn's disease and ulcerative colitis attention to be paid to the age at manifestation]. MMW Fortschr Med; 2009 May; 151(19):38-9. PubMed ID: 19827443 [No Abstract] [Full Text] [Related]
13. A report on efficacy and safety of azathioprine in a group of inflammatory bowel disease patients in northwest Greece. Christodoulou D; Katsanos K; Baltayannis G; Tzabouras N; Tsianos EV Hepatogastroenterology; 2003; 50(52):1021-4. PubMed ID: 12845970 [TBL] [Abstract][Full Text] [Related]
14. [Ulcerative colitis and Crohn's disease of the colon. Problems of diagnosis and therapy. Immunological aspects]. Cassano C; Torsoli A; Perlmann P Minerva Med; 1972 Dec; 63(88):4813-4. PubMed ID: 4539300 [No Abstract] [Full Text] [Related]
15. Medical management of patients with difficult-to-treat inflammatory bowel disease. van Hogezand RA Neth J Med; 1994 Aug; 45(2):55-9. PubMed ID: 7936006 [TBL] [Abstract][Full Text] [Related]
16. Inflammatory bowel disease. Part II. Hansen R Proc Annu Meet Med Sect Am Counc Life Insur; 1978; ():41-9. PubMed ID: 39296 [No Abstract] [Full Text] [Related]
17. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506). Fellermann K; Ludwig D; Stahl M; David-Walek T; Stange EF Am J Gastroenterol; 1998 Oct; 93(10):1860-6. PubMed ID: 9772045 [TBL] [Abstract][Full Text] [Related]
19. A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration. Nathan DM; Iser JH; Gibson PR J Gastroenterol Hepatol; 2008 Jun; 23(6):954-8. PubMed ID: 17559377 [TBL] [Abstract][Full Text] [Related]
20. [Therapeutic alternatives in Crohn disease and in ulcero-hemorrhagic rectocolitis: current findings]. Louis E; Belaiche J; Delwaide J; Gast P Rev Med Liege; 1992 Nov; 47(11):573-8. PubMed ID: 1462064 [No Abstract] [Full Text] [Related] [Next] [New Search]